Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 181

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

PT322 – Kimberly Juroviesky, Capt, USAF, Retired – Ketamine and...

Conflicting States of Consciousness: Exploring Psilocin and Sleep

Oregon, Measure 109, and Religious Freedom: The Final Vote

PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics:...

Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule;...

PT320 – Anne Philippi – The New Health Club, Intergenerational Trauma,...

PT319 – Kole – Activism and Trust: A Cautionary Tale From...

DO-Why? The Story of DOI

Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety...

PT318 – Del Jolly, Rashad Evans, and Jake Plummer – Functional...

Load more

EDITOR PICKS

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©